A003120 Stock Overview
Operates as a pharmaceutical company in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Ilsung Is Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩15,080.00 |
| 52 Week High | ₩20,650.00 |
| 52 Week Low | ₩14,500.00 |
| Beta | -0.35 |
| 1 Month Change | -1.76% |
| 3 Month Change | -6.34% |
| 1 Year Change | -24.56% |
| 3 Year Change | -8.16% |
| 5 Year Change | -17.69% |
| Change since IPO | 892.11% |
Recent News & Updates
Recent updates
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Feb 20
Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?
Jan 16Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like
Dec 18
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Nov 21Shareholder Returns
| A003120 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.7% | -0.4% | -1.0% |
| 1Y | -24.6% | -1.6% | -11.5% |
Return vs Industry: A003120 underperformed the KR Pharmaceuticals industry which returned -1.6% over the past year.
Return vs Market: A003120 underperformed the KR Market which returned -11.5% over the past year.
Price Volatility
| A003120 volatility | |
|---|---|
| A003120 Average Weekly Movement | 1.6% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in KR Market | 12.5% |
| 10% least volatile stocks in KR Market | 2.8% |
Stable Share Price: A003120 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A003120's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | n/a | Seok-geun Yoon | www.ilsungis.com |
Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular system products. The company was formerly known as Ilsung Pharmaceuticals Co., Ltd.
Ilsung Is Co., Ltd. Fundamentals Summary
| A003120 fundamental statistics | |
|---|---|
| Market cap | ₩103.98b |
| Earnings (TTM) | ₩13.09b |
| Revenue (TTM) | ₩69.02b |
8.0x
P/E Ratio1.5x
P/S RatioIs A003120 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003120 income statement (TTM) | |
|---|---|
| Revenue | ₩69.02b |
| Cost of Revenue | ₩42.04b |
| Gross Profit | ₩26.98b |
| Other Expenses | ₩13.88b |
| Earnings | ₩13.09b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.88k |
| Gross Margin | 39.09% |
| Net Profit Margin | 18.97% |
| Debt/Equity Ratio | 0% |
How did A003120 perform over the long term?
See historical performance and comparisonDividends
9.9%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 10:27 |
| End of Day Share Price | 2025/04/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ilsung Is Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.